BiomimX is a biotechnology company that develops clinically relevant in-vitro models of human organs and pathologies for drug discovery and development. Their platform presents the next generation of preclinical models: human, dynamic, and 3D. Every tissue in the body is subjected to motion, and BiomimX's beating organs-on-chips brings this motion into the 3D native microenvironment offering the next generation of clinically relevant human in-vitro setups. They can help researchers create their own model according to specific needs to build up a wide spectrum of organ models.
